Does Intravenous XXXX Dose Influence the Duration of Recovery Room Stay Following Outpatient Third Molar Surgery?

@entity1 @entity6058 @entity1363 @entity3652
PURPOSE: To evaluate the impact of intravenous @entity1363 dose on the duration of recovery room stay for @entity1 undergoing outpatient third molar surgery. MATERIALS AND METHODS: Using a retrospective cohort study design, a sample of @entity1 undergoing outpatient third molar surgery under intravenous sedation at Mayo Clinic from 2010 to 2014 was identified. All @entity1 underwent extraction of all 4 third molars during a single operative procedure and the age range was limited to 14 to 29  years. The primary predictor variable was the total dose of intravenous @entity1363 administered during sedation. The primary outcome variable was recovery room length of stay  (LOS) after completion of surgery. Multiple covariates also abstracted included @entity1 age, gender, American Society of Anesthesiologists (ASA) score, duration of surgical procedure, complexity of surgical procedure, types and dosages of all intravenous medications administered during sedation, and volume of crystalloid fluid administered perioperatively. Univariable and multivariable models were developed to evaluate associations between the primary predictor variable and covariates relative to the primary outcome variable. RESULTS: The study sample was composed of 2,610 @entity1 . Mean age was 18.3  years (SD, 3.0  yr; range, 14 to 29  yr) and gender distribution was 52% female. Mean dosage of @entity1363 administered was 4.1  mg (SD, 1.1  mg; range, 0.5 to 10.0  mg). Variables predicting shorter LOS at multivariable analysis included older age (P < .001), male gender (P  = .004), and administration of larger crystalloid fluid volumes (P  <  .001). Variables predicting longer LOS included higher ASA score (P < .001), administration of @entity3652 (P < .001), and administration of @entity6058 (P < .001). The dose of @entity1363 administered during sedation was not found to be significantly associated with prolonged recovery room LOS in univariable or multivariable settings. CONCLUSION: Dosage of intravenous @entity1363 does not appear to significantly impact the duration of recovery room stay in the prototypical @entity1 undergoing sedation for outpatient third molar surgery.
